Breaking News Instant updates and real-time market news.

MAXR

Maxar Technologies

$18.77

-0.59 (-3.05%)

17:30
11/16/18
11/16
17:30
11/16/18
17:30

Maxar Technologies shareholders approve U.S. domestication

Maxar Technologies announced that shareholders approved the company's U.S. domestication at a special meeting held earlier today in Westminster, Colorado. A total of 227 holders of common shares of the company, representing approximately 76% of the company's issued and outstanding common shares, voted in connection with the meeting, with 99.8% voting in favor of the U.S. domestication and more than 99.8% of the common shares and LTIP Units voted at the meeting, voting as a single class, voted in favor of the U.S. domestication. Following the U.S. domestication effective date, Maxar will continue to list its shares on both the New York Stock Exchange and Toronto Stock Exchange. Maxar does not anticipate that the U.S. domestication will have any impact on its employees, customers, suppliers, or other key stakeholders. As previously announced, Maxar will transition to U.S. GAAP accounting standards and U.S. domestic securities filings effective with its U.S. domestication. The company believes this transition will make its financial results more transparent to a wider audience of investors and provide increased comparability with U.S. aerospace and defense peer companies. Subject to obtaining required court approvals, as well as the satisfaction of other conditions precedent, Maxar anticipates that the U.S. domestication will be completed on or about January 1, 2019.

MAXR Maxar Technologies
$18.77

-0.59 (-3.05%)

11/01/18
TDSI
11/01/18
DOWNGRADE
TDSI
Buy
Maxar Technologies downgraded to Buy from Action List Buy at TD Securities
11/01/18
CIBC
11/01/18
DOWNGRADE
CIBC
Neutral
Maxar Technologies downgraded to Neutral from Outperformer at CIBC
11/01/18
BMOC
11/01/18
NO CHANGE
Target $35
BMOC
Outperform
Maxar Technologies price target lowered to $35 from $76 at BMO Capital
BMO Capital analyst Thanos Moschopoulos lowered his price target on Maxar Technologies to $35 after its "disappointing" Q3 and reduced guidance for FY18 amid challenges in its GEO business. The analyst also lowers his FY18 EPS view to $4.09 from $4.81 and FY19 view to $4.41 from $4.92. Moschopoulos keeps his Outperform rating however and contends that the post-earnings sell-off is overdone as it currently trades at just 7-times expected FY18 EBITDA of its Imaging and Services segment while fully discounting the value of the rest of the business.
11/01/18
RBCM
11/01/18
NO CHANGE
Target $40
RBCM
Outperform
Maxar Technologies price target lowered to $40 from $57 at RBC Capital
RBC Capital analyst Steve Arthur lowered his price target on Maxar Technologies to $40 after its "disappointing" Q3 results and the $384M impairment. The analyst sees the 45% decline in the stock price as too severe however, keeping his Outperform rating while noting that the risk-reward profile around the GEO review merits some optimism. Arthur adds that the company's implied valuation of 3.2-times expected FY20 earnings is well below the peer' average of 14.7-times.

TODAY'S FREE FLY STORIES

AVY

Avery Dennison

$115.99

2.085 (1.83%)

06:45
04/24/19
04/24
06:45
04/24/19
06:45
Earnings
Avery Dennison reports Q1 adjusted EPS $1.48, consensus $1.45 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 18

    May

06:45
04/24/19
04/24
06:45
04/24/19
06:45
General news
Breaking General news story  »

Week of 4/19 MBA Mortgage…

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

06:44
04/24/19
04/24
06:44
04/24/19
06:44
Periodicals
Coinbase shutters Chicago office, lays off about 30 engineers, Forbes reports »

Coinbase is shuttering…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TFX

Teleflex

$280.05

5.46 (1.99%)

06:43
04/24/19
04/24
06:43
04/24/19
06:43
Downgrade
Teleflex rating change  »

Teleflex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 13

    Nov

CDXC

ChromaDex

$4.22

0.225 (5.63%)

06:41
04/24/19
04/24
06:41
04/24/19
06:41
Hot Stocks
ChromaDex signs Tru Niagen distribution partnership in Canada with WELL Health »

ChromaDex announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$35.88

0.95 (2.72%)

06:41
04/24/19
04/24
06:41
04/24/19
06:41
Earnings
Boston Scientific narrows FY19 adj. EPS view to $1.54-$1.58 from $1.53-$1.58 »

Consensus $1.56. Narrows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 18

    May

  • 20

    May

  • 29

    May

  • 26

    Jun

  • 13

    Nov

TSEM

TowerJazz

$17.73

0.28 (1.60%)

06:40
04/24/19
04/24
06:40
04/24/19
06:40
Downgrade
TowerJazz rating change  »

Credit Suisse downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 28

    May

ZBH

Zimmer Biomet

$122.76

1.64 (1.35%)

06:39
04/24/19
04/24
06:39
04/24/19
06:39
Upgrade
Zimmer Biomet rating change  »

Zimmer Biomet upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 10

    May

NOC

Northrop Grumman

$292.59

9.73 (3.44%)

06:39
04/24/19
04/24
06:39
04/24/19
06:39
Hot Stocks
Northrop Grumman CEO says 'captured substantial new awards' in Q1 »

"In first quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 15

    May

  • 29

    May

CPF

Central Pacific

$29.52

0.62 (2.15%)

06:39
04/24/19
04/24
06:39
04/24/19
06:39
Earnings
Central Pacific reports Q1 EPS 55c, consensus 50c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 26

    Apr

RCKT

Rocket Pharmaceuticals

$19.32

1.54 (8.66%)

06:39
04/24/19
04/24
06:39
04/24/19
06:39
Conference/Events
Rocket Pharmaceuticals management to meet with Evercore ISI »

Luncheon with Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

NOC

Northrop Grumman

$292.59

9.73 (3.44%)

06:38
04/24/19
04/24
06:38
04/24/19
06:38
Earnings
Northrop Grumman raises FY19 adj. EPS view to $18.90-$19.30 from $18.50-$19.00 »

FY19 consensus $18.96.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 15

    May

  • 29

    May

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

06:37
04/24/19
04/24
06:37
04/24/19
06:37
Periodicals
SoftBank founder lost $130M on personal bitcoin investment, WSJ reports »

SoftBank Group (SFTBF)…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARX

RA Pharmaceuticals

$21.95

0.68 (3.20%)

06:37
04/24/19
04/24
06:37
04/24/19
06:37
Hot Stocks
RA Pharmaceuticals presents pre-clinical data for zilucoplan XR »

Ra Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKR

Acadia Realty Trust

$28.19

0.505 (1.82%)

06:36
04/24/19
04/24
06:36
04/24/19
06:36
Conference/Events
Acadia Realty Trust management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

  • 09

    May

  • 28

    May

  • 29

    May

  • 04

    Jun

PHM

PulteGroup

$31.34

1.11 (3.67%)

06:36
04/24/19
04/24
06:36
04/24/19
06:36
Upgrade
PulteGroup rating change  »

PulteGroup upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

BSX

Boston Scientific

$35.88

0.95 (2.72%)

06:36
04/24/19
04/24
06:36
04/24/19
06:36
Earnings
Boston Scientific sees Q2 adj. EPS 37c-39c, consensus 39c »

Sees Q2 revenue up 5%-7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 18

    May

  • 20

    May

  • 29

    May

  • 26

    Jun

  • 13

    Nov

NOC

Northrop Grumman

$292.59

9.73 (3.44%)

06:36
04/24/19
04/24
06:36
04/24/19
06:36
Earnings
Northrop Grumman reports Q1 EPS $5.06, consensus $4.58 »

Reports Q1 revenue $8.2B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 15

    May

  • 29

    May

FND

Floor & Decor

$47.36

2.04 (4.50%)

06:36
04/24/19
04/24
06:36
04/24/19
06:36
Recommendations
Floor & Decor analyst commentary  »

Floor & Decor price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 16

    May

PB

Prosperity Bancshares

$72.11

0.975 (1.37%)

06:35
04/24/19
04/24
06:35
04/24/19
06:35
Earnings
Prosperity Bancshares reports Q1 EPS $1.18, consensus $1.16 »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

TRK

Speedway Motorsports

$13.98

0.27 (1.97%)

06:34
04/24/19
04/24
06:34
04/24/19
06:34
Hot Stocks
Sonic Financial proposes to acquire Speedway Motorsports for $18.00 per share »

Speedway Motorsports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

BSX

Boston Scientific

$35.88

0.95 (2.72%)

06:33
04/24/19
04/24
06:33
04/24/19
06:33
Earnings
Boston Scientific reports Q1 adj. EPS 35c, consensus 36c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 18

    May

  • 20

    May

  • 29

    May

  • 26

    Jun

  • 13

    Nov

TSEM

TowerJazz

$17.73

0.28 (1.60%)

06:32
04/24/19
04/24
06:32
04/24/19
06:32
Downgrade
TowerJazz rating change  »

TowerJazz downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 28

    May

MKTX

MarketAxess

$262.60

0.44 (0.17%)

06:32
04/24/19
04/24
06:32
04/24/19
06:32
Earnings
MarketAxess reports Q1 EPS $1.39, consensus $1.37 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 02

    May

SNAP

Snap

$11.99

0.46 (3.99%)

06:32
04/24/19
04/24
06:32
04/24/19
06:32
Upgrade
Snap rating change  »

Snap upgraded to In Line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.